Octreotide Teva

Medicinal product

(Invented) name

Octreotide Teva

Active substance (s)

Oktreotidas

Strength

10 mg

Pharmaceutical form

milteliai ir tirpiklis pailginto atpalaidavimo injekcinei suspensijai

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

H01CB02, Octreotide

Marketing authorisation holder

Teva B.V., Nyderlandai

Date of authorisation

2019-07-02

Date of renewal

2024-01-30

Documents

Stage

Perregistruotas

Controlled?

Controlled substance type

Legal basis

10(1)

Procedure number

CZ/H/0801/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Flakone yra	2 ml
Oktreotidas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
102109	88211	1088211	flakonas	milteliai, tirpiklio užpildytas švirkštas (2 ml), flakono adapteris ir saugi injekcinė adata N1		Receptinis	LT/1/19/4418/001	Netiekiama	-	-	No	-	-	Download
102110	88212	1088212	flakonas	milteliai, tirpiklio užpildytas švirkštas (2 ml), flakono adapteris ir saugi injekcinė adata N3		Receptinis	LT/1/19/4418/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-01-30	Perregistruotas
2019-07-02	Registruotas